Related Experiment Video

Updated: May 12, 2026

Lumican Extraction from Amniotic Membrane and Determination of its Storage Temperature
04:21

Lumican Extraction from Amniotic Membrane and Determination of its Storage Temperature

Published on: October 14, 2022

Molecular mechanism of the inhibition effect of Lipoxin A4 on corneal dissolving pathology process

Hong-Yan Zhou1, Ji-Long Hao, Miao-Miao Bi

  • 1Department of Ophthalmology, China-Japan Union Hospital of Jilin University, Changchun 130033, Jilin Province, China.

International Journal of Ophthalmology
|April 4, 2013
PubMed
Abstract

Insights

Lipoxin A4 (LXA4) effectively inhibits corneal collagen degradation by reducing matrix metalloproteinases (MMPs) and their inhibitors. This finding suggests LXA4

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Biochemistry

Background:

  • Corneal ulceration involves excessive tissue degradation mediated by matrix metalloproteinases (MMPs).
  • MMPs are activated by cytokines and chemokines, contributing to corneal pathology.
  • Lipoxin A4 (LXA4) is investigated for its potential role in modulating these processes.

Purpose of the Study:

  • To investigate the molecular mechanism of Lipoxin A4 (LXA4) in regulating three-dimensional corneal collagen degradation.
  • To determine LXA4's effect on MMPs and tissue inhibitors of metalloproteinases (TIMPs) in corneal fibroblasts.

Main Methods:

  • Rabbit corneal fibroblasts were cultured in a three-dimensional collagen matrix.
  • The effects of LXA4 on collagen degradation were assessed by measuring hydroxyproline levels.
  • Expression and activity of MMPs (-1, -2, -3, -9) and TIMPs (-1, -2) were analyzed using immunoblotting and zymography.

Main Results:

  • LXA4 significantly inhibited corneal collagen degradation in a dose- and time-dependent manner.
  • LXA4 suppressed IL-1β-induced increases in pro-MMP and active MMP levels.
  • LXA4 also inhibited IL-1β-induced upregulation of TIMP-1 and TIMP-2.

Conclusions:

  • Lipoxin A4 (LXA4) acts as a potent anti-inflammatory agent by inhibiting corneal collagen degradation.
  • LXA4 mitigates IL-1β-induced matrix metalloproteinase activity in corneal fibroblasts.
  • These findings highlight LXA4's therapeutic potential in managing corneal dissolving pathologies.
Keywords:
IL-1βcollagencorneadissolutionlipoxin A4

Related Concept Videos

Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH01:21

Factors Affecting Dissolution: Drug pKa, Lipophilicity and GI pH

Drug absorption within the gastrointestinal (GI) tract is a complex process influenced by several critical factors, including the site pH, the drug's dissociation constant (pKa), and the drug's lipophilicity. The GI tract exhibits a pH gradient, with an acidic environment in the stomach and a more alkaline environment in the small intestine. This pH variation directly affects the ionization state of drugs.
A drug's pKa and the pH of the gastrointestinal (GI) tract play crucial roles in drug...
Local Anesthetics: Pharmacokinetics01:13

Local Anesthetics: Pharmacokinetics

The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
Local Anesthetics: Mechanism of Action01:23

Local Anesthetics: Mechanism of Action

Local anesthetics (LAs) block sensory and motor impulses by inhibiting the sodium channels on the nerve cell membranes. This induces temporary loss of sensation, relieving pain in a specific body area.
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
Indirect-Acting Cholinergic Agonists: Pharmacokinetics01:22

Indirect-Acting Cholinergic Agonists: Pharmacokinetics

Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they are...
Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin, triggering...